Pseudofolliculitis Barbae in Military Service Members: Shaving Waivers, Treatment, and Policy Changes

Conclusions

• Pseudofolliculitis barbae is a common, chronic inflammatory shaving disorder that disproportionately affects Black and other patients with tightly curled hair, and it can also be influenced by genetic susceptibility.
• The most effective prevention is reducing close shaving trauma, so conservative measures like shaving technique changes, single-blade clippers, topical therapies, and chemical depilatories are first-line options for milder disease.
• Laser hair removal is an effective option for refractory pseudofolliculitis barbae, but it is semi-permanent, may limit future beard growth, and is not equally accessible to all service members.
• Military shaving policies have changed repeatedly, but the current trend is toward shorter, more restrictive waivers and greater command involvement rather than long-term or permanent exemptions.
• Recent policy changes may increase barriers to care, create retention and recruitment problems, and potentially make severe pseudofolliculitis barbae a disqualifying condition for some service members.
• Shaving waivers are not just cosmetic accommodations; they are associated with stigma, negative career perceptions, and delayed promotion outcomes in at least some military populations.
• Pseudofolliculitis barbae affects a substantial portion of the military population, especially Black service members, and can lead to permanent scarring if not treated early and effectively.
• Civilian dermatologists can play an important role by documenting severity, prior treatment failure, and willingness or unwillingness to pursue laser hair removal, because these details affect military waiver decisions.
• Evidence-based, transparent, and standardized grooming-waiver policies are needed across service branches, with stronger support for permanent waivers in severe or refractory cases.
• When treating active-duty patients, clinicians should always ask about the patient’s military job and duty status because even routine dermatologic diagnoses and medications can affect deployability and career eligibility.